ABBVMEGA

AbbVie Inc.

HealthcareDrug Manufacturers - General
$206.15
$0.02(-0.97%)
52W$176.57
$244.81
Updated May 6, 12:00 AM
RSI51
RS Rating34/99
Beta0.34
Volatility25%
F-Score6/9
Mkt Cap$364.6B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

AbbVie Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 34), showing significant lag compared to the market leaders. Earnings growth of 57% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.

Relative Strength
34
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
0.34
vs S&P 500
LOW VOL
52W Position
43%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$213.75
50 SMA > 100 SMA$218.86
100 SMA > 150 SMA$221.96
150 SMA > 200 SMA$218.10

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$205.77+0.19%ABOVE
50 SMA$213.75-3.55%BELOW
100 SMA$218.86-5.81%BELOW
150 SMA$221.96-7.12%BELOW
200 SMA$218.10-5.48%BELOW

Price Performance

1D-1.0%
1W+4.3%
1M-0.2%
3M-5.9%
6M-4.9%
YTD-10.1%
1Y+5.1%
3Y+11.7%
52-Week Trading Range43% from low
$206.15
52W Low$176.57
52W High$244.81

Technical Indicators

RSI (14)NEUTRAL
50.8
305070
VCP ScoreCOOL
3/10
Base depth: 22.5%

Risk Profile

Beta
0.34
52W Vol
25%
ATR
$5.80
Max DD (1Y)
-19%

Volume Analysis

Today
3.20M
50D Avg
5.91M
Vol Ratio
0.54x
Liquidity
VERY LIQUID

Earnings Momentum

Q1'25-6%
$0.72
Q2'25-31%
$0.53
Q3'25-89%
$0.10
Q4'25+5735%
$1.02
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+10.34%
5 Years:+5.95%
3 Years:+1.75%
TTM:+8.57%

Compounded Profit Growth

10 Years:-2.74%
5 Years:-2.72%
3 Years:-29.03%
TTM:-1.36%

Stock Price CAGR

10 Years:+12.70%
5 Years:+12.23%
3 Years:+11.67%
1 Year:+5.14%

Return on Equity

10Y Avg:862.6%
5Y Avg:1293.1%
3Y Avg:2104.0%
Last Year:6214.7%

Key Metrics

Market Cap$364.6B
Gross Margin70.2%
Net Margin6.9%
Piotroski F-Score6/9

Frequently Asked Questions

Is ABBV in an uptrend right now?

ABBV has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is ABBV overbought or oversold?

ABBV's RSI (14) is 51. The stock is in neutral territory, neither overbought nor oversold.

Is ABBV outperforming the market?

ABBV has a Relative Strength (RS) Rating of 34 out of 99. ABBV is currently lagging the broader market.

Where is ABBV in its 52-week range?

ABBV is trading at $206.15, which is 84% of its 52-week high ($244.81) and 43% above its 52-week low ($176.57).

How volatile is ABBV?

ABBV has a Beta of 0.34 and 52-week volatility of 25%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.